US HB1676 | 2011-2012 | 112th Congress
Status
Spectrum: Strong Partisan Bill (Democrat 13-1)
Status: Introduced on May 2 2011 - 25% progression, died in committee
Action: 2011-05-05 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 2 2011 - 25% progression, died in committee
Action: 2011-05-05 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Tanning Bed Cancer Control Act of 2011 - Directs the Commissioner of Food and Drugs (FDA): (1) to complete a study to examine the classification of ultraviolet tanning lamps as class I medical devices; and (2) not later than one year after completion of such study, to either issue a rule providing for the reclassification of an ultraviolet tanning lamp as a class II or class III device or submit to Congress a report providing a justification for not issuing such a rule. Requires the Commissioner to: (1) complete a study on the adequacy of performance standards established for ultraviolet tanning lamps; and (2) either issue a rule providing for more stringent performance standards for such lamps, including with respect to the strength of ultraviolet rays emitted by such devices and the amount of time a user should remain exposed to such devices, or submit to Congress a report providing a justification for not issuing such a rule. Directs the Commissioner to carry out recommendations made in a report on labeling requirements for indoor tanning devices regarding ultraviolet tanning lamps. Declares that nothing in this Act shall be construed to limit the authority of the Commissioner with regard to an ultraviolet tanning lamp.
Title
Tanning Bed Cancer Control Act of 2011
Sponsors
Rep. Carolyn Maloney [D-NY] | Rep. Earl Blumenauer [D-OR] | Rep. Gerald Connolly [D-VA] | Rep. Jim Cooper [D-TN] |
Rep. Joe Courtney [D-CT] | Rep. Charles Dent [R-PA] | Rep. Jesse Jackson [D-IL] | Rep. Eddie Johnson [D-TX] |
Rep. Dennis Kucinich [D-OH] | Sen. Edward Markey [D-MA] | Rep. James McGovern [D-MA] | Rep. James Moran [D-VA] |
Rep. Jackie Speier [D-CA] | Rep. Lynn Woolsey [D-CA] |
History
Date | Chamber | Action |
---|---|---|
2011-05-05 | House | Referred to the Subcommittee on Health. |
2011-05-02 | House | Referred to the House Committee on Energy and Commerce. |
2011-05-02 | House | Sponsor introductory remarks on measure. (CR E778-779) |
Subjects
Administrative law and regulatory procedures
Cancer
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Government studies and investigations
Health
Musculoskeletal and skin diseases
Cancer
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Government studies and investigations
Health
Musculoskeletal and skin diseases
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/112th-congress/house-bill/1676/all-info |
Text | https://www.congress.gov/112/bills/hr1676/BILLS-112hr1676ih.pdf |